{"id":24099,"date":"2016-09-02T12:51:17","date_gmt":"2016-09-02T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=24099"},"modified":"2018-04-14T02:12:34","modified_gmt":"2018-04-14T07:12:34","slug":"24099","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/24099\/","title":{"rendered":"Not\u00edcias e notas sobre sa\u00fade animal de 2 de setembro de 2016"},"content":{"rendered":"

compat\u00edvel com impressora<\/a><\/p>\n

***********************************
\nBrakke Consulting's
\nNot\u00edcias e notas sobre sa\u00fade animal de 2 de setembro de 2016<\/strong>
\nCopyright \u00a9 Brakke Consulting, Inc.
\n 
\nEditor: Lynn Fondon DVM MBA
\n************************************
\nNAS NOTICIAS:
\n 
\nNovidades da Brakke Consulting<\/u>
\nCanal OTC
\n 
\nnot\u00edcias de ganhos<\/u>
\nAnatara Lifesciences
\nFibro<\/p>\n

outras not\u00edcias<\/u>
\nParticipa\u00e7\u00f5es de refer\u00eancia
\nDechra
\nEvax
\nGallant Laborat\u00f3rios Personalizados
\nIDT Biologika
\nNestl\u00e9 Purina
\nValneva
\nZoetis (GeneMax)
\nZoetis (Cefshot)<\/p>\n

 
\n***********************************
\nBRAKKE CONSULTING, INC.
\nENTENDENDO O MERCADO DE BOLSA<\/strong><\/p>\n

Se sua empresa est\u00e1 considerando os canais OTC para novas oportunidades de neg\u00f3cios ou voc\u00ea distribui nos canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade para empresas que buscam aprender mais sobre os detalhes dos canais OTC de distribui\u00e7\u00e3o. Se voc\u00ea estiver procurando informa\u00e7\u00f5es significativas sobre os canais OTC, as tend\u00eancias encontradas l\u00e1 e as oportunidades existentes, entre em contato com nosso escrit\u00f3rio em Dallas ou Joel Adamson em jadamson@brakkeconsulting.com<\/a>.<\/p>\n

www.BrakkeConsulting.com<\/a><\/p>\n

***********************************
\nRELEASES DE RESULTADOS DA EMPRESA<\/p>\n

\u2022 A Phibro Animal Health Corporation anunciou seus resultados financeiros para o ano fiscal encerrado em 30 de junho de 2016. As vendas l\u00edquidas da Animal Health no ano foram de $486 milh\u00f5es, um aumento de 3%. Excluindo o ano anterior de $8 milh\u00f5es de receitas marcantes de licenciamento de vacinas, as vendas l\u00edquidas de Sa\u00fade Animal cresceram 5%. (comunicado de imprensa da empresa)<\/p>\n

\u2022 A Anatara Lifesciences divulgou resultados para o ano fiscal encerrado em 30 de junho de 2016. A empresa registrou uma perda de Aus$(0,7) milh\u00f5es (US$0,5 milh\u00f5es) em compara\u00e7\u00e3o com uma perda de Aus$(1,8) milh\u00f5es no ano fiscal anterior. As receitas totais do ano foram de Aus$2,3 milh\u00f5es (US$1,6 milh\u00f5es), em compara\u00e7\u00e3o com zero vendas no ano fiscal anterior. (Farm\u00e1cia Animal)
\n 
\n 
\n**********************************
\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/p>\n

\u2022 Zoetis, Angus Genetics, Inc. (AGI) e Certified Angus Beef (CAB) anunciaram atualiza\u00e7\u00f5es no GeneMax Advantage para ajudar nas decis\u00f5es de manuten\u00e7\u00e3o\/abate de novilhas de reposi\u00e7\u00e3o, bem como decis\u00f5es de reprodu\u00e7\u00e3o e marketing para opera\u00e7\u00f5es comerciais de cria\u00e7\u00e3o de bezerros. As atualiza\u00e7\u00f5es incluem efeitos de marcadores atualizados, suposi\u00e7\u00f5es econ\u00f4micas atualizadas, uma popula\u00e7\u00e3o de refer\u00eancia ampliada para compara\u00e7\u00e3o de animais e relat\u00f3rios de caracter\u00edsticas individuais. (Agwired. com)<\/p>\n

\u2022 A Dechra Veterinary Products anunciou o lan\u00e7amento dos PhycoDent Rawhide Chews. PhycoDent Chews s\u00e3o projetados n\u00e3o apenas para a sa\u00fade bucal de um animal de estima\u00e7\u00e3o, mas tamb\u00e9m para apoiar a sa\u00fade das articula\u00e7\u00f5es. (Vantagem veterin\u00e1ria)<\/p>\n

\u2022 A Purina anunciou o lan\u00e7amento das f\u00f3rmulas enlatadas e secas EN gastroent\u00e9ricas caninas com baixo teor de gordura da Pro Plan Veterinary Diet. (comunicado de imprensa da empresa)<\/p>\n

\u2022 A Zoetis do Reino Unido anunciou o lan\u00e7amento no Reino Unido do Cefshot (cefal\u00f4nio), um antibi\u00f3tico intramam\u00e1rio de cefalosporina para vacas secas de pr\u00f3xima gera\u00e7\u00e3o, indicado para o tratamento de mastite subcl\u00ednica na secagem, com a\u00e7\u00e3o contra bact\u00e9rias Gram positivas e Gram negativas. (Vetsurgeon. com)<\/p>\n

\u2022 CANAD\u00c1 Gallant Custom Laboratories, uma subsidi\u00e1ria da IDT Biologika, anunciou um acordo de licen\u00e7a comercial com a Valneva que d\u00e1 \u00e0 Gallant acesso \u00e0 linha celular EB66 da Valneva para impulsionar o desenvolvimento de sua linha principal de vacinas para gado e aves. (Farm\u00e1cia Animal)<\/p>\n

\u2022 A UK Benchmark Holdings anunciou uma parceria com a empresa su\u00ed\u00e7a Evax para desenvolver uma vacina recombinante para prevenir e tratar o sweet itch, uma resposta imunit\u00e1ria al\u00e9rgica \u00e0 saliva do mosquito Culicoides, em cavalos. A divis\u00e3o de sa\u00fade animal da Benchmark pagar\u00e1 1,12 milh\u00f5es de libras esterlinas ($1,47 milh\u00f5es) e contribuir\u00e1 com mais 4 milh\u00f5es de libras esterlinas nos pr\u00f3ximos quatro anos para o desenvolvimento da vacina, em troca dos direitos mundiais de vendas, distribui\u00e7\u00e3o e fabrica\u00e7\u00e3o do produto (excluindo a Su\u00ed\u00e7a). (Farm\u00e1cia Animal)
\n 
\n 
\n***********************************
\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/p>\n

\u2022 EUA \u2013 GRIPE AVIANA O USDA informou que a cepa H5N2 da gripe avi\u00e1ria altamente patog\u00eanica (HPAI) foi detectada em um pato selvagem de um ref\u00fagio estadual de vida selvagem perto de Fairbanks. Esta \u00e9 a primeira detec\u00e7\u00e3o do H5N2 nos EUA desde junho de 2015. (Agri-Pulse)<\/p>\n

\u2022 REINO UNIDO \u2013 PESQUISA SOBRE A GRIPE AVI\u00c1RIA Uma nova pesquisa realizada pelo Instituto Pirbright indica que os genes de algumas galinhas as tornam quase resistentes \u00e0 gripe avi\u00e1ria. Os pesquisadores examinaram duas linhagens geneticamente distintas de galinhas e descobriram que as aves portadoras do v\u00edrus eram geneticamente resistentes \u00e0 doen\u00e7a e s\u00f3 transmitiam o v\u00edrus atrav\u00e9s do trato respirat\u00f3rio e por um per\u00edodo limitado de tempo; aves suscet\u00edveis \u00e0 doen\u00e7a tamb\u00e9m excretam o v\u00edrus nas fezes e por um per\u00edodo mais longo. (Farm\u00e1cia Animal)<\/p>\n

************************************
\nPONTO DE VISTA DA BRAKKE CONSULTORIA<\/p>\n

Encerramos mais um m\u00eas e com o in\u00edcio de setembro \u00e9 claramente outono em algumas partes dos EUA. A maioria das empresas est\u00e1 agora confort\u00e1vel com as suas previs\u00f5es para o balan\u00e7o do ano e est\u00e1 a concluir o seu processo de planeamento e or\u00e7amento para 2017. \u00c0 medida que nos aproximamos de 2017, n\u00e3o parece haver quaisquer entradas significativas de novos produtos no horizonte pr\u00f3ximo. <\/p>\n

Teremos a conclus\u00e3o da fus\u00e3o da Boehringer Ingelheim e da Merial no final de 2016, e o processo de integra\u00e7\u00e3o continuar\u00e1 durante a maior parte de 2017, se n\u00e3o mais. Haver\u00e1 outra fus\u00e3o entre as 20 maiores empresas neste ano ou em 2017? Com base no hist\u00f3rico de consolida\u00e7\u00e3o em sa\u00fade animal, esperar\u00edamos pelo menos uma fus\u00e3o adicional entre as 10 maiores e diversas aquisi\u00e7\u00f5es menores nos pr\u00f3ximos 18 meses. <\/p>\n

Para aqueles que est\u00e3o nos EUA, tenham um \u00f3timo e seguro fim de semana de feriado do Dia do Trabalho! Volte revigorado e pronto para encerrar o terceiro trimestre e depois o ano inteiro.<\/p>\n

Ron Brakke
\n 
\n**********************************
\nEste boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.
\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<\/p>\n

Para obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em www.brakkeconsulting.com<\/a>.
\n 
\nBrakke Consulting, Inc.
\n12005 Ford Rd., Suite 530
\nDallas, TX 75234 EUA<\/p>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

Portugu\u00eas: vers\u00e3o para impress\u00e3o *********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 2 de setembro de 2016 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Not\u00edcias sobre lucros do canal OTC Anatara Lifesciences Phibro outras not\u00edcias Benchmark Holdings Dechra Evax Gallant Custom Laboratories IDT Biologika Nestle Purina Valneva Zoetis (GeneMax) Zoetis (Cefshot) *********************************** BRAKKE CONSULTING, INC. ENTENDENDO O MERCADO DE DISTRIBUI\u00c7\u00c3O SEM RECEITA N\u00e3o importa se sua empresa est\u00e1 considerando os canais OTC para novas oportunidades de neg\u00f3cios ou se voc\u00ea distribui nos canais OTC h\u00e1 anos, a equipe da Brakke Consulting pode fornecer assist\u00eancia significativa e de qualidade para empresas que buscam aprender mais sobre os detalhes dos canais de distribui\u00e7\u00e3o OTC. Se voc\u00ea estiver procurando por insights significativos sobre os canais OTC, as tend\u00eancias encontradas l\u00e1 e as oportunidades que existem, entre em contato com nosso escrit\u00f3rio em Dallas ou Joel Adamson em jadamson@brakkeconsulting.com. www.BrakkeConsulting.com ************************************ DIVULGA\u00c7\u00d5ES DE RESULTADOS DA EMPRESA \u2022 A Phibro Animal Health Corporation anunciou seus resultados financeiros para o ano fiscal encerrado em 30 de junho de 2016. As vendas l\u00edquidas da Animal Health para o ano foram de $486 milh\u00f5es, um aumento de 3%. Excluindo a receita do marco de licenciamento de vacinas de $8 milh\u00f5es do ano anterior, as vendas l\u00edquidas da Animal Health cresceram 5%. (comunicado \u00e0 imprensa da empresa) \u2022 A Anatara Lifesciences relatou os resultados para o ano fiscal encerrado em 30 de junho de 2016. A empresa registrou um preju\u00edzo de Aus$(0,7) milh\u00f5es (US$0,5<\/p>\n

Ver postagem completa<\/a><\/div>\n

;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-24099","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/24099\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly *********************************** Brakke Consulting’s Animal Health News & Notes for September 2, 2016 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news OTC Channel   earnings news Anatara Lifesciences Phibro other news Benchmark Holdings Dechra Evax Gallant Custom Laboratories IDT Biologika Nestle Purina Valneva Zoetis (GeneMax) Zoetis (Cefshot)   *********************************** BRAKKE CONSULTING, INC. UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution.  If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at jadamson@brakkeconsulting.com. www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES • Phibro Animal Health Corporation announced its financial results for its fiscal year ended June 30, 2016. Animal Health net sales for the year were $486 million, an increase of 3%. Excluding the prior year $8 million of vaccine licensing milestone revenue, Animal Health net sales grew 5%. (company press release) • Anatara Lifesciences reported results for the fiscal year ended June 30, 2016.  The company posted a loss of Aus$(0.7) million (US$0.5View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/24099\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-02T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:12:34+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/24099\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/24099\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News & Notes for September 2, 2016\",\"datePublished\":\"2016-09-02T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:12:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/24099\/\"},\"wordCount\":925,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/24099\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/24099\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\"},\"datePublished\":\"2016-09-02T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:12:34+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/24099\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/24099\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/24099\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/zh\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News & Notes for September 2, 2016\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/24099\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly *********************************** Brakke Consulting’s Animal Health News & Notes for September 2, 2016 Copyright © Brakke Consulting, Inc.   Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS:   Brakke Consulting news OTC Channel   earnings news Anatara Lifesciences Phibro other news Benchmark Holdings Dechra Evax Gallant Custom Laboratories IDT Biologika Nestle Purina Valneva Zoetis (GeneMax) Zoetis (Cefshot)   *********************************** BRAKKE CONSULTING, INC. UNDERSTANDING THE OVER-THE-COUNTER MARKET Whether your business is considering the OTC channels for new business opportunities or you have been distributing in the OTC channels for years, Brakke Consulting’s team can provide significant and quality assistance to businesses seeking to learn more about the details of the OTC channels of distribution.  If you are looking for meaningful insights into the OTC channels, the trends found there, and the opportunities that exist, contact our Dallas office or Joel Adamson at jadamson@brakkeconsulting.com. www.BrakkeConsulting.com *********************************** COMPANY EARNINGS RELEASES • Phibro Animal Health Corporation announced its financial results for its fiscal year ended June 30, 2016. Animal Health net sales for the year were $486 million, an increase of 3%. Excluding the prior year $8 million of vaccine licensing milestone revenue, Animal Health net sales grew 5%. (company press release) • Anatara Lifesciences reported results for the fiscal year ended June 30, 2016.  The company posted a loss of Aus$(0.7) million (US$0.5View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/24099\/","og_site_name":"Brakke Consulting Website","article_published_time":"2016-09-02T17:51:17+00:00","article_modified_time":"2018-04-14T07:12:34+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/24099\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/24099\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News & Notes for September 2, 2016","datePublished":"2016-09-02T17:51:17+00:00","dateModified":"2018-04-14T07:12:34+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/24099\/"},"wordCount":925,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/24099\/","url":"https:\/\/brakkeconsulting.com\/pt\/24099\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#website"},"datePublished":"2016-09-02T17:51:17+00:00","dateModified":"2018-04-14T07:12:34+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/24099\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/24099\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/24099\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/zh\/"},{"@type":"ListItem","position":2,"name":"Animal Health News & Notes for September 2, 2016"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/zh\/#website","url":"https:\/\/brakkeconsulting.com\/zh\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/zh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/zh\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24099","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=24099"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24099\/revisions"}],"predecessor-version":[{"id":25533,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/24099\/revisions\/25533"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=24099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=24099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=24099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}